Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...
CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
Dimerix completes patient enrolment in ACTION3 phase 3 trial of DMX-200 to treat focal segmental glomerulosclerosis: Melbourne, Australia Tuesday, December 16, 2025, 18:00 Hrs [IS ...
Suraksha Diagnostics, in collaboration with Medikabazaar–United Imaging, launches uAcademy to advance radiology education: Our Bureau, Mumbai Tuesday, December 16, 2025, 16:30 H ...
The 3rd Edition of Remarkable Women Camaraderie 2026 & Awards, set to take place on February 6, 2026, in Goa, is born from the belief that when women come together, exchange stories, and uplift one ...
IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business: Nandita Vijaysimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] ...
India’s lifescience starts-ups see regulatory compliance as a key hurdle for growth: Nandita Vijayasimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] Indian lifescienc ...
Commerce ministry to facilitate industry connect with regulators on December 17 to boost pharma exports: Shardul Nautiyal, Mumbai Tuesday, December 16, 2025, 08:00 Hrs [IST] In or ...
Panel recommends health ministry to set up industry advisory board: Gireesh Babu, New Delhi Tuesday, December 16, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Health and Famil ...
US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease: Shanghai Tuesday, ...
Amsterdam, the Netherlands Tuesday, December 16, 2025, 17:00 Hrs [IST] ...
DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Tuesday, December 16, 2025, 13:50 Hrs [IST] Dnyaan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results